Kindly Md, Inc. shares rise 4.00% premarket after Biogen Inc. received a Complete Response Letter from the FDA for the high dose regimen of nusinersen for the treatment of spinal muscular atrophy.

miércoles, 24 de septiembre de 2025, 4:08 am ET1 min de lectura
NAKA--
Kindly Md, Inc. rose 4% in premarket trading. The company's stock price increase is not directly related to the news events provided.

Kindly Md, Inc. shares rise 4.00% premarket after Biogen Inc. received a Complete Response Letter from the FDA for the high dose regimen of nusinersen for the treatment of spinal muscular atrophy.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios